Project Number 1R43AG067939-01A1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Mechanistic Validation of Selective Brain-Penetrant HDAC6 Inhibitors as a Disease- Modifying Treatment for Tauopathies including Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator KRANZ, JANICE E. Principal Investigator First Name JANICE E. Principal Investigator Last Name KRANZ Awardee Organization EIKONIZO THERAPEUTICS, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $509,672 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
